MiNK Therapeutics, Inc. (INKT) plans to release its financial results for the first quarter of 2026
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
At the same time, the company will also highlight the R&D progress made by its proprietary platform in several iNKT cell therapy projects. This information release aims to provide investors with a comprehensive understanding of the company's financial condition and the advancement of its core therapeutic technology pipeline.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Silver surged 7% while gold only rose 0.4% – why?
金十•2026/05/12 15:34
Spot Gold Extends Intraday Losses to 2%, Now Trading at $4640.33 per Ounce
BlockBeats•2026/05/12 15:26
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$80,457.69
-0.64%
Ethereum
ETH
$2,266.39
-2.35%
Tether USDt
USDT
$0.9997
+0.02%
XRP
XRP
$1.43
-2.74%
BNB
BNB
$654.32
-0.60%
USDC
USDC
$0.9996
-0.01%
Solana
SOL
$94.38
-1.10%
TRON
TRX
$0.3478
-0.97%
Dogecoin
DOGE
$0.1088
-0.80%
Hyperliquid
HYPE
$40.39
-2.02%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now